Research output per year
Research output per year
- 15 results
Search results
-
2024
FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction
van Eijck, C. H. J., Strijk, G., Vietsch, E. E., van der Sijde, F., Verheij, M., Mustafa, D. A. M., Vink, M., Aerts, J. G. J. V., van Eijck, C. H. J. & Willemsen, M., Jan 2024, In: European Journal of Cancer. 196, 113440.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Citations (Scopus)20 Downloads (Pure) -
2023
Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients
de Koning, W., van Eijck, C. H. J., van der Sijde, F., Strijk, G. J., Oostvogels, A. A. M., Debets, R., van Eijck, C. H. J. & Mustafa, D. A. M., 31 Aug 2023, In: Cancers. 15, 17, 15 p., 4349.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile25 Downloads (Pure) -
A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma
van Eijck, C. H. J., de Koning, W., van der Sijde, F., Moskie, M., Groot Koerkamp, B., Homs, M. Y. V., van der Burg, S. H., van Eijck, C. H. J. & Mustafa, D. A. M., Mar 2023, In: European Journal of Cancer. 181, p. 119-134 16 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile9 Citations (Scopus)61 Downloads (Pure) -
2022
Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients
van der Sijde, F., Dik, W. A. A., Mustafa, D. A. M., Vietsch, E. E. E., Besselink, M. G. G., Debets, R., Koerkamp, B. G., Haberkorn, B. C. M., Homs, M. Y. V., Janssen, Q. P. P., Luelmo, S. A. C., Mekenkamp, L. J. M., Oostvogels, A. A. M., Smits-te Nijenhuis, M. A. W., Wilmink, J. W. W. & van Eijck, C. H. J., 25 Aug 2022, In: Frontiers in Immunology. 13, 12 p., 898498.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile11 Citations (Scopus)72 Downloads (Pure) -
Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study
van der Sijde, F., van Dam, J. L., Koerkamp, B. G., Haberkorn, B. C. M., Homs, M. Y. V., Mathijssen, D., Besselink, M. G., Wilmink, J. W. & van Eijck, C. H. J., 7 Jul 2022, In: Journal of Oncology. 2022, 9 p., 8549487.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile7 Citations (Web of Science)19 Downloads (Pure) -
Quality of life of locally advanced pancreatic cancer patients after FOLFIRINOX treatment
van der Sijde, F., Schafthuizen, L., van ’t Land, F. R., Moskie, M., van Laarhoven, H. W. M., van Dijk, M. & van Eijck, C. H. J., Mar 2022, In: Supportive Care in Cancer. 30, 3, p. 2407-2415 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Citations (Scopus)16 Downloads (Pure) -
2021
Organoids derived from neoadjuvant FOLFIRINOX patients recapitulate therapy resistance in pancreatic ductal adenocarcinoma
Farshadi, E. A., Chang, J., Sampadi, B., Doukas, M., Van’t Land, F., van der Sijde, F., Vietsch, E. E., Pothof, J., Koerkamp, B. G. & van Eijck, C. H. J., 1 Dec 2021, In: Clinical Cancer Research. 27, 23, p. 6602-6612 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile27 Citations (Scopus)47 Downloads (Pure) -
Preoperative serum ADAM12 levels as a stromal marker for overall survival and benefit of adjuvant therapy in patients with resected pancreatic and periampullary cancer
Strijker, M., van der Sijde, F., the Dutch Pancreatic Cancer Group, Suker, M., Boermeester, M. A., Bonsing, B. A., Bruno, M. J., Busch, O. R., Doukas, M., van Eijck, C. H., Gerritsen, A., Groot Koerkamp, B., Haj Mohammad, N., van Hilst, J., de Hingh, I. H., van Hooft, J. E., Luyer, M. D., Quintus Molenaar, I., Verheij, J. & Waadorp, C. & 4 others, , Dec 2021, In: HPB. 23, 12, p. 1886-1896 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Citations (Scopus)22 Downloads (Pure) -
Serum mir-373-3p and mir-194-5p are associated with early tumor progression during folfirinox treatment in pancreatic cancer patients: A prospective multicenter study
van der Sijde, F., Homs, M. Y. V., van Bekkum, M. L., van den Bosch, T. P. P., Bosscha, K., Besselink, M. G., Bonsing, B. A., de Groot, J. W. B., Karsten, T. M., Koerkamp, B. G., Haberkorn, B. C. M., Luelmo, S. A. C., Mekenkamp, L. J. M., Mustafa, D. A. M., Wilmink, J. W., van Eijck, C. H. J. & Vietsch, E. E., 9 Oct 2021, In: International Journal of Molecular Sciences. 22, 20, 10902.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile12 Citations (Scopus)91 Downloads (Pure) -
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX
van der Sijde, F., Azmani, Z., Besselink, M. G., Bonsing, B. A., de Groot, J. W. B., Groot Koerkamp, B., Haberkorn, B. C. M., Homs, M. Y. V., van IJcken, W. F. J., Janssen, Q. P., Lolkema, M. P., Luelmo, S. A. C., Mekenkamp, L. J. M., Mustafa, D. A. M., van Schaik, R. H. N., Wilmink, J. W., Vietsch, E. E. & van Eijck, C. H. J., 18 Aug 2021, In: Therapeutic Advances in Medical Oncology. 13, 14 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile10 Citations (Scopus)34 Downloads (Pure) -
Circulating Immunological Biomarkers: Prognosis of Pancreatic Cancer Patients Reflected by the Immune System
van der Sijde, F., Mustafa, D. A. M., Vietsch, E. E., Katsikis, P. D. & van Eijck, C. H. J., 1 Aug 2021, In: Pancreas. 50, 7, p. 933-941 9 p.Research output: Contribution to journal › Article › Academic › peer-review
5 Citations (Scopus) -
2020
RNA from stabilized whole blood enables more comprehensive immune gene expression profiling compared to RNA from peripheral blood mononuclear cells
van der Sijde, F., Li, Y., Schraauwen, R., de Koning, W., van Eijck, C. & Mustafa, D., 2020, In: PLoS One (print). 15, 6, e0235413.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile14 Citations (Scopus)26 Downloads (Pure) -
Serum miR-338-3p and miR-199b-5p are associated with the absolute neutrophil count in patients with resectable pancreatic cancer
van der Sijde, F., Vietsch, E., Mustafa, D., Li, Y. & van Eijck, C., 2020, In: Clinica Chimica Acta. 505, p. 183-189 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile11 Citations (Scopus)49 Downloads (Pure) -
2019
Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients
van der Sijde, F., Vietsch, E., Mustafa, D., Besselink, M., Groot Koerkamp, B. & van Eijck, C., 2019, In: Cancers. 11, 1, 93.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile23 Citations (Scopus)27 Downloads (Pure) -
Immune-Related Circulating miR-125b-5p and miR-99a-5p Reveal a High Recurrence Risk Group of Pancreatic Cancer Patients after Tumor Resection
Vietsch, E., Peran, I., Suker, M., van den Bosch, T., van der Sijde, F., Kros, J. M., van Eijck, C. & Wellstein, A., 2019, In: Applied Sciences {Basel}. 9, 22, 4784.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Citations (Scopus)18 Downloads (Pure)